Soy Isoflavones Ameliorate the Adverse Effects of Chemotherapy in Children
- 23 September 2010
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 62 (7) , 1001-1005
Abstract
Genistein sensitizes cancer cells to chemotherapy and radiation by modulating cell survival pathways. At the same time, genistein's antioxidant and anti-inflammatory effects may protect normal tissues from adverse effects of chemotherapy and radiation, which are largely due to oxygen-free radicals and inflammation. We conducted a small pilot study with a soy isoflavone mixture containing 8 mg of genistein in children receiving chemotherapy and/or radiation to investigate genistein's potential toxicity preventive effect. We monitored clinical and laboratory parameters in children with cancer who received their first cycle of chemotherapy without genistein and the subsequent cycles with genistein. Patients served as their own controls, and the clinical-laboratory data from the first cycle were compared to the data from subsequent cycles. Nine cycles of chemotherapy were administered without genistein and 57 cycles with genistein. Patients experienced less myelosuppression, mucositis, and infection when they received genistein with chemotherapy. During supplementation, serum genistein levels were 2 to 6 times higher compared to presupplementation levels. Patients who received abdominal radiation reported less pain and diarrhea when they took the genistein supplement. Further clinical investigation of soy isoflavones in pediatric cancer patients receiving chemotherapy and/or radiation should be conducted.Keywords
This publication has 22 references indexed in Scilit:
- Isoflavone effect on gene expression profile and biomarkers of inflammationJournal of Pharmaceutical and Biomedical Analysis, 2010
- Isoflavones Prevent Endoplasmic Reticulum Stress-Mediated Neuronal Degeneration by Inhibiting Tau Hyperphosphorylation in SH-SY5Y CellsJournal of Medicinal Food, 2009
- Soy isoflavones and immunityThe Journal of Medical Investigation, 2008
- A Phase II Randomized, Placebo-Controlled Clinical Trial of Purified Isoflavones in Modulating Steroid Hormones in Men Diagnosed With Localized Prostate CancerNutrition and Cancer, 2007
- Soy isoflavones enhance radiotherapy in a metastatic prostate cancer modelInternational Journal of Cancer, 2007
- Antitumor and Antimetastatic Activities of Docetaxel Are Enhanced by Genistein through Regulation of Osteoprotegerin/Receptor Activator of Nuclear Factor-κB (RANK)/RANK Ligand/MMP-9 Signaling in Prostate CancerCancer Research, 2006
- Retracted: Cisplatin‐induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC‐3 pancreatic tumor xenograftsCancer, 2006
- Potentiation of the radiation effect with genistein in cervical cancer cellsGynecologic Oncology, 2005
- Inactivation of Nuclear Factor κB by Soy Isoflavone Genistein Contributes to Increased Apoptosis Induced by Chemotherapeutic Agents in Human Cancer CellsCancer Research, 2005
- The role of isoflavones in cancer chemopreventionFrontiers in Bioscience-Landmark, 2004